ArticleProceedings (Baylor University. Medical Center)2026

Hormonal therapy and cardiovascular risk in polycystic ovary syndrome: a propensity-matched cohort study.

Revati Varma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.